Successful acne management in Apert syndrome twins

Pediatric Dermatology

Volumn 22, Issue 6, 2005, Pages 561-565

  Benjamin, Latanya T ^a   Trowers, Andrea B ^a   Schachner, Lawrence A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; DOXYCYCLINE; ISOTRETINOIN; MINOCYCLINE; TETRACYCLINE;

ACNE VULGARIS; ACROCEPHALOSYNDACTYLY; ADOLESCENT; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; MALE; PATIENT REFERRAL; PENETRANCE; PIGMENT DISORDER; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SYMPTOM; TWINS; ARTICLE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; HOSPITALIZATION; RISK ASSESSMENT; TREATMENT OUTCOME;

ACNE VULGARIS; ACROCEPHALOSYNDACTYLIA; ADOLESCENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TETRACYCLINE; TREATMENT OUTCOME; TWINS;

EID: 33644789444     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2005.00141.x     Document Type: Review

References (18)

1. Henderson CA, Knaggs H, Clark A, et al. Apert's syndrome and androgen receptor staining of the basal cells of the sebaceous glands. Br J Dermatol 1995 132 : 139 143.
2. Johnson KB, Oski FA. Common syndromes with morphologic abnormalities. In : Johnson KB, Oski FA, eds. Oski's essential pediatrics. Philadelphia : Lippincott-Raven Publishers, 1997 : 656.
3. Downs AM, Con don CA, Tan R. Isotretinoin treatment for antibiotic-refractory acne in Apert's syndrome. Clin Exp Dermatol 1999 24 : 461 463.
4. Haslem R. Craniosynostosis. In : Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics, 16th ed. Philadelphia : W.B. Saunders Company, 2000 : 1812 1813.
5. Apert ME. De l'acrocephalosynactylie. Bull Mem Soc Med Hosp Paris 1906 23 : 1510.
6. Steffen C. The acne form eruption of Apert's syndrome is not acne vulgaris. Am J Dermatopatho 1984 6 : 213 220.
7. Solomon LM, Fretzin D, Pruzansky S. Pilosebaceous abnormalities in Apert's syndrome. Arch Dermatol 1970 102 : 381 385.
8. Walton S, Wyatt EH, Cunliffe WJ. Genetic control of sebum excretion and acne-A twin study. Br J Dermatol 1988 118 : 393 396.
9. Gelmetti CC, Krowchuk DP, Lucky AW. Acne. In : Schachner LA, Hansen RC, eds. Pediatric dermatology, 3rd ed. Philadelphia : Elsevier Limited, 2003 : 600.
10. Parker TL, Roth JG. Isotretinoin for acne in Apert's. Pediatr Dermatol 1992 9 : 298 300.
11. Gilaberte M, Puig L, Alomar A. Isotretinoin treatment of acne in a patient with Apert Syndrome. Pediatr Dermatol 2003 20 : 443 446.
12. Campanati A, Marconi B, Penna L, et al. Pronounced and early acne in Apert's syndrome: a case successfully treated with oral isotretinoin. Eur J Dermatol 2002 12 : 496 498.
13. Robison D, Wilms NA. Successful treatment of the acne of Apert syndrome with isotretinoin. J Am Acad Dermatol 1989 21 : 315 316.
14. Jick SS, Kremers HM, Vastlakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000 136 : 1231 1236.
15. Carey BM, Parkin GJ, Cunliffe WJ, et al. Skeletal toxicity with isotretinoin therapy: a clinical radiological evaluation. Br J Dermatol 1988 119 : 609 614.
16. Bigby M, Stern R. Adverse reactions to isotretinoin. J Am Acad Dermatol 1988 3 : 543 552.
17. Charalabopoulos K, Papalimneou V, Charalabopoulos A, et al. Two new adverse effects of isotretinoin. Br J Dermatol 2003 148 : 593.
18. Campis LB. Children with Apert syndrome: developmental and psychologic considerations. Clin Plast Surg 1991 18 : 409 416.